Eiman Y Ibrahim
5PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 26, 2026
Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients.Saira Munshani, Eiman Y Ibrahim, Rozalyn L Rodwin
|Jan 16, 2026
Recurrent Orbital Metastases in Follicular Variant Papillary Thyroid Carcinoma After Recombinant Human Thyrotropin.Eiman Ibrahim, Lilamani Kurukulasuriya, Tabitha Galloway
|Apr 04, 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.Kim R M Blenman, Michal Marczyk, Thomas Karn
|Feb 04, 2022
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.Julia Foldi, Andrea Silber, Emily Reisenbichler
|Feb 09, 2021
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.Julia Foldi, Andrea Silber, Emily Reisenbichler
Pageof 1
Frequent Collaborators
3 joint publications
Julia Foldi
3 joint publications
Michal Marczyk
3 joint publications
David L Rimm
3 joint publications
Lajos Pusztai
2 joint publications
Emily Reisenbichler
2 joint publications
Kim R M Blenman
1 joint publications
Thomas Karn
1 joint publications
Vesal Yaghoobi
1 joint publications
Andrea Silber
1 joint publications
Carsten Denkert
